Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Vtv Theraptcs Cl A (VTVT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 87,555
  • Shares Outstanding, K 50,319
  • Annual Sales, $ 12,430 K
  • Annual Income, $ -7,910 K
  • 60-Month Beta -3.79
  • Price/Sales 7.04
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -0.16
  • Number of Estimates 1
  • High Estimate -0.16
  • Low Estimate -0.16
  • Prior Year -0.29
  • Growth Rate Est. (year over year) +44.83%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.28 +34.38%
on 04/25/19
1.91 -9.95%
on 05/23/19
+0.38 (+28.36%)
since 04/24/19
3-Month
1.26 +36.40%
on 04/17/19
2.62 -34.35%
on 02/25/19
-0.67 (-28.03%)
since 02/22/19
52-Week
0.68 +152.94%
on 09/17/18
6.09 -71.76%
on 10/03/18
+0.03 (+1.78%)
since 05/24/18

Most Recent Stories

More News
vTv Therapeutics Announces 2019 First Quarter Financial Results and Update

vTv Therapeutics Inc. (Nasdaq:VTVT) today reported financial results for the first quarter that ended March 31, 2019, and provided an update on recent achievements and upcoming events....

VTVT : 1.72 (-1.15%)
Report: Developing Opportunities within Apergy, vTv Therapeutics, Arcimoto, Lipocine, Zealand Pharma A/S, and AquaBounty Technologies -- Future Expectations, Projections Moving into 2019

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Apergy Corporation (NYSE:APY), vTv...

AQB : 2.14 (+0.94%)
VTVT : 1.72 (-1.15%)
FUV : 2.95 (unch)
APY : 30.87 (-4.49%)
LPCN : 1.57 (-1.26%)
ZEAL : 21.57 (+1.48%)
Zacks.com featured highlights include: VALE, Second Sight, Carbonite, Arconic and vTv

Zacks.com featured highlights include: VALE, Second Sight, Carbonite, Arconic and vTv

CARB : 24.53 (-0.53%)
EYES : 0.71 (unch)
VTVT : 1.72 (-1.15%)
ARNC : 22.25 (+0.18%)
VALE : 12.02 (+1.95%)
Get Over Bargain Hunting: Tap 5 Stocks With Rising P/E

Bet on these top-ranked stocks with rising P/E to realize outsized gains.

CARB : 24.53 (-0.53%)
EYES : 0.71 (unch)
VTVT : 1.72 (-1.15%)
ARNC : 22.25 (+0.18%)
VALE : 12.02 (+1.95%)
vTv Therapeutics to Present at the 14th International Conference on Alzheimer's & Parkinson's Diseases

vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered treatments for Alzheimer's disease...

VTVT : 1.72 (-1.15%)
vTv Therapeutics Announces $15 Million of Class A Common Stock Financings

vTv Therapeutics Inc. (Nasdaq:VTVT) (the "Company") today announced that it has entered into a definitive agreement with certain institutional investors for the purchase and sale in a registered...

VTVT : 1.72 (-1.15%)
vTv Therapeutics Announces 2018 Fourth Quarter and Full Year Financial Results and Update

vTv Therapeutics Inc. (Nasdaq:VTVT) today reported financial results for the fourth quarter and year that ended December 31, 2018, and provided an update on recent achievements and...

VTVT : 1.72 (-1.15%)
Watch These 4 Healthcare Stocks Set the Pace on Friday (1/25/19)

CORAL GABLES, FL / ACCESSWIRE / January 25, 2019 / The market has become increasingly more exciting over the last few months, with headlines detailing inventive treatments and strategic acquisitions popping...

RWLK : 2.95 (+2.43%)
VTVT : 1.72 (-1.15%)
WEED.TO : 59.70 (-0.53%)
PHGI.CN : 0.460 (-1.08%)
PHGRF : 0.3403 (-0.21%)
CGC : 44.42 (-0.31%)
vTv Therapeutics Announces Publication of Comprehensive Data in Science Translational Medicine Detailing the Discovery and Clinical Development of TTP399, including Results of Phase 2 AGATA Study

vTv Therapeutics Inc. (Nasdaq: VTVT) today announced the publication of a paper in Science Translational Medicine showcasing the discovery and development of TTP399, an investigational,...

VTVT : 1.72 (-1.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade VTVT with:

Business Summary

vTv Therapeutics Inc. is a biopharmaceutical company which is engaged in the discovery and development of orally administered small molecule drug candidates to fill unmet medical needs. Its drug candidate for the treatment of Alzheimers disease includes azeliragon TTP488, which is in Phase III clinical...

See More

Key Turning Points

2nd Resistance Point 1.85
1st Resistance Point 1.78
Last Price 1.72
1st Support Level 1.65
2nd Support Level 1.59

See More

52-Week High 6.09
Fibonacci 61.8% 4.02
Fibonacci 50% 3.38
Fibonacci 38.2% 2.75
Last Price 1.72
52-Week Low 0.68

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar